Biomarkers and the AD continuum

Professor Henrik Zetterberg, Sweden

Research and DiagnosticsBiomarkers


Biomarkers and the AD continuum


Professor Henrik Zetterberg, Sweden

September 30, 2022



"Alzheimer’s is a disease process that starts much earlier than we thought”

In just ten years, biomarkers have substantially improved our understanding and the way we diagnose Alzheimer’s disease.

Watch what else Professor Henrik Zetterberg has to say on the use of biomarkers & Alzheimer's Disease.



Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.